BD Kiestraâ„¢ MRSA Imaging Application Helps Enhance Microbiology Laboratory Efficiency and Workflow
FRANKLIN LAKES, N.J., May 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new BD Kiestraâ„¢ Methicillin-resistant Staphylococcus aureus (MRSA) imaging application that uses artificial intelligence (AI) to interpret bacterial growth and release negative specimens with minimal human interaction.
Read more at prnewswire.com